05.09.2019
- The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...
05.09.2019
- The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...
08.08.2019
- In a transaction valued at around $2.4 billion including net debt, US small molecule innovator and API specialist Cambrex has agreed to be acquired by an affiliate of the Permira...
22.11.2018
- Cambrex Corporation, which bills itself as the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), has agreed to acquire Avista...
26.10.2018
- East Rutherford, NJ/USA-based Cambrex Corporation is investing approximately $3 million to increase the capacity and efficiency of one of its cGMP manufacturing facilities at its...
19.09.2018
- Recently, the pharmaceutical contract development and manufacturing organization (CDMO) industry has been extremely active in M&A, as is the pharma and generics industry itself...
19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
25.07.2018
- Cambrex, a US-based small molecule innovator and developer of generic Active Pharmaceutical Ingredients (APIs), has agreed to acquire compatriot Contract Development and...
